✦ LIBER ✦

Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma

✍ Scribed by Alberto Fabbri; Mariapia Lenoci; Alessandro Gozzetti; Ida Chitarrelli; Francesca Olcese; Donatella Raspadori; Marco Gobbi; Francesco Lauria

Book ID: 108675369
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 451 KB
Volume: 139
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2007.06746.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose oral fludarabine plus cyclophos

Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia

✍ Francesco Forconi; Alberto Fabbri; Mariapia Lenoci; Elisa Sozzi; Alessandro Gozz 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

## Abstract Fludarabine plus cyclophosphamide (FC) at conventional doses is an effective treatment for chronic lymphocytic leukaemia (CLL). However, FC at standard doses may give hematological and non‐hematological toxicity, predominantly in the elderly. Intravenous or oral low‐dose FC regimens rem

Treatment of therapy-related acute myelo

Treatment of therapy-related acute myeloid leukemia occurring in elderly non-Hodgkin lymphoma patients with low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor

✍ Hiro Tatetsu; Fumihiko Matsuno; Noritaka Takatsu; Hirosada Miyake; Koyu Hoshino; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 86 KB

P-476 Phase II study of gemcitabine plus

P-476 Phase II study of gemcitabine plus oxaliplatin as first-line treatment in elderly or unfit patients with advanced non-small cell lung cancer (NSCLC). Across

✍ Domènech, M.; Losa, F.; Blanco, R.; Nogué, M.; Montesinos, J.; Mesía, C.; Gallar 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 295 KB